Edico Genome has raised $10m from Qualcomm Ventures and Axon to accelerate the analysis of gene sequencing data.
US-based health company Edico Genome, a provider of genomic mapping for uncovering genetic markers, has received $10m in a series A round led by Qualcomm Ventures, the corporate venturing division of semiconductor producer Qualcomm.
The round also included venture firm Axon Ventures and angel investor Greg Lucier, previously the chairman and chief executive of Life Technologies. Lucier has also been appointed to the Edico Genome board of directors.
Edico will use the funding to promote Edico’s DRAGEN bio-IT processor, which…
